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Abstract
Background: Intermittent measurement of cardiac output may be performed using a lithium
dilution technique (LiDCO). This can then be used to calibrate a pulse power algorithm of the
arterial waveform which provides a continuous estimate of this variable. The purpose of this study
was to examine the duration of accuracy of the pulse power algorithm in critically ill patients with
respect to time when compared to measurements of cardiac output by an independent technique.
Methods:  Pulse power analysis was performed on critically ill patients using a proprietary
commercial monitor (PulseCO). All measurements were made using an in-dwelling radial artery
line and according to manufacturers instructions. Intermittent measurements of cardiac output
were made with LiDCO in order to validate the pulse power measurements. These were made at
baseline and then following 1, 2, 4 and 8 hours. The LiDCO measurement was considered the
reference for comparison in this study. The two methods of measuring cardiac output were then
compared by linear regression and a Bland Altman analysis. An error rate for the limits of
agreement (LOA) between the two techniques of less than 30% was defined as being acceptable
for this study.
Results: 14 critically ill medical and surgical patients were enrolled over a three month period. At
baseline patients showed a wide range of cardiac output (median 7.5 L/min, IQR 5.1 -9.0 L/min).
The bias and limits of agreement between the two techniques was deemed acceptable for the first
four hours of the study with percentage errors being 29%, 22%, and 285 respectively. The
percentage error at eight hours following calibration increased to 36%. The ability of the PulseCo
to detect changes in cardiac output was assessed with a similar analysis. The PulseCO tracked the
changes in cardiac output with adequate accuracy for the first four hours with percentage errors
being 20%, 24% and 25%. However at eight hours the error had increased to 43%.
Conclusion:  The agreement between lithium dilution cardiac output and the pulse power
algorithm in the PulseCO monitor remains acceptable for up to four hours in critically ill patients.
Background
The measurement of cardiac output is an important com-
ponent of the management of critically ill haemodynam-
ically unstable patients[1,2]. In recent years there has been
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increasing emphasis towards the less invasive or mini-
mally- invasive monitoring tools [3-10]. There are a
number of commercially available monitors that measure
cardiac output from an intra-arterial pressure line. These
utilize different algorithms to relate changes in arterial
pressure to changes in stroke volume and thus cardiac out-
put [1,2,4,8,9,11]. To date the most accepted of these
devices have required an independent form of validation
or calibration of cardiac output. This calibration remains
valid so long as there are no significant changes in the
haemodynamic status of the patients. It is unclear as to
when and under what conditions this re-calibration
should be performed.
The LiDCOplus monitor (LiDCO, Cambridge, UK) is a
device that combines a pulse power algorithm (PulseCO)
with an independent form of calibrating the pulse power
algorithm via lithium dilution (LiDCO) [3]. This device
has been validated in a number of different clinical and
veterinary conditions. To our knowledge there are no data
showing how well the algorithm maintains its accuracy
during an eight hour interval free of calibration in a mixed
(medical/surgical) adult intensive care population of crit-
ically ill patients. This study, therefore seeks to investigate
the duration that the two methods remain sufficiently
similar to be acceptable for clinical use.
Methods
Patients
Adult critically ill patients who for clinical reasons were
being monitored with the LiDCOplus cardiac output
monitor on the General Intensive Care Unit at St George's
Hospital were enrolled into the study. All patients, or their
next of kin where appropriate, gave written informed con-
sent to the study as had been previously agreed with the
Local Research Ethics Committee of St George's Health-
care NHS Trust. All patients were critically ill and had both
a radial arterial catheter and a central venous line in-situ.
Any patient who was less than 40 kg in weight or had sig-
nificant aortic regurgitation was excluded from this study.
Protocol
At baseline the PulseCO was calibrated using the lithium
dilution technique as previously described and according
to manufacturer's instructions[8]. This method involves
the placing of 0.3 mmols of lithium chloride in an ind-
welling central venous line and then the rapid flushing of
this line with 20 ml of 0.9% saline. This ensures a rapid
bolus of lithium chloride is introduced into the circula-
tion. A lithium specific sensor connected to the arterial
line then detects the change in lithium ion concentration
in blood that is then passed across the sensor at a fixed
rate by a specialized pump. The detection of this concen-
tration by the sensor generates a lithium dilution curve.
This is analysed and a reference cardiac output generated.
This is the procedure that is recommended by the manu-
facturers of the device.
A LiDCO measurement was taken at baseline and then at
1, 2, 4 and 8 hours subsequently. These were done only
during intervals relatively free of haemodynamic change.
This was defined as being five minutes in which there were
no alterations in vasoactive medications, no contempo-
rary fluid challenges, no changes in heart rate (HR) or
changes in mean arterial pressure (MAP) of more than 10
%. The PulseCO measurement was equalized to the
LiDCO measurement only at baseline. Subsequent meas-
urements of PulseCO at the same intervals as the measure-
ments of the LiDCO were taken but the measurements
were not equalized at these points to reset the PulseCO
system. The PulseCO value was recorded as the mean of
the value immediately before and after the lithium dilu-
tion.
Statistical analysis
Data are expressed as means with a standard error when
normally distributed and a median with an interquartile
range when not. In this study the measurement of cardiac
output from lithium dilution was considered the refer-
ence method for comparison. PulseCO measurements
were thus compared against the LiDCO measurement for
each individual time-point. This study is comparing two
independent methods of measuring cardiac output each
with their own inherent rate of error. Comparison
between these measurements was performed by linear
regression analysis and the technique described by Bland
and Altman[12]. We defined a level of agreement between
the two techniques of less than 30% as being clinically
acceptable as described by Critchley and Critchley[13].
This value is based on an assumption that for cardiac out-
put monitoring a new device should have a similar level
of precision to the intermittent thermodilution from a
pulmonary artery catheter that has a precision of approxi-
mately 10%. If the new tested device was to have a similar
precision, then the percentage error for agreement
between the two techniques should be less than 28% as
calculated by dividing twice the standard deviation of the
differences by the mean cardiac output for both tech-
niques. The PulseCO algorithm is designed to track
changes in cardiac output. We therefore also analysed the
data with respect to changes in this variable. The absolute
values of these changes are not as important as the per-
centage change in relation to the actual value, so this is
presented as a percentage change from the previous read-
ing and plotted as both a linear regression plot and a
Bland Altman analysis [14]. Single plots of PulseCo and
LiDCO against time for each patient were made in order
to show the agreement between the two measurements for
individual patients. All analyses were performed usingBMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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Graphpad Prism software system of Graphpad Software
Inc.
Results
Fourteen patients were enrolled into the study. Six of
these patients were male and eight female. They had a
median age of 67.5 (29–76) years, a median height of
1.66 (1.6–1.73) m and a median weight of 67 (58–102)
kg. Five of the patients were post surgery and all were crit-
ically ill from a number of different aetiologies [Table 1].
Eight patients had multiple organ failure due to sepsis (6
medical, 2 surgical). The remaining six patients had acute
heart failure (3 medical, 2 post partum, 1 surgical). In all
fourteen patients measurements were available at base-
line, 1 hour, 2 hours and 4 hours. In two patients data at
eight hours were unavailable due to clinical priorities
meaning the patients had had to be removed from the
study [Table 2]. All the measurements were suitable for
analysis. A total number of 54 pairs of data were available
at the end of data collection.
The baseline data show a large range of cardiac outputs
(LiDCO from 2.8 to 18.3 L/min) with a median cardiac
output of 7.5 (5.1 to 9.0) L/min. The median heart rate
was 104 (92–117) beats per minute, median arterial pres-
sure 81 (72–93) mmHg and median central venous pres-
sure 16 (12–19) mmHg [Table 2]. Seven patients were
receiving a norepinephrine infusion to support the mean
arterial pressure at the beginning and throughout the
study period. Over the eight hour study period six of the
fourteen patients had changes in their cardiac output of
greater than 15% from their baseline value [Table 2].
At baseline, the cardiac output of the PulseCO system was
equalized with the independent form of measurement
(the LiDCO) meaning that the two monitors displayed
exactly the same number. This absolute value of cardiac
output from the PulseCO system remained acceptable as
compared to the LiDCO for the next four hours of the
study. Data for PulseCO and LiDCO at 1, 2 and 4 hours
demonstrated an acceptable levels of bias and limits of
agreement for the first four hours of the study, however at
eight hours following calibration the PulseCO device had
a percentage error that was outside of the acceptable range
[Figure 1]. After one hour of study, the bias and limits of
agreement between PulseCO and LiDCO were -0.3 ± 2.3
L/min with a percentage error of 29%, at two hours 0.1 ±
1.9 (22%), at four hours -0.1 ± 2.2 (28%) and at eight
hours 0.2 ± 2.2 (36%) [Table 3].
The PulseCO system utilizes a pulse power algorithm to
track changes in cardiac output from a baseline value. It is
therefore important to also assess whether the changes in
cardiac output between the two devices were of similar
direction and magnitude. In this study there were signifi-
cant agreements between the two techniques of detecting
changes in cardiac output for the first four hours follow-
ing calibration. This is evidenced from the significant cor-
relation between percentage changes in the cardiac output
from the preceding time point as measured by the Pul-
seCO when compared to changes as measured by the
LiDCO method (r2 0.46–0.76, p < 0.006). At eight hours
the changes in cardiac output were not significantly corre-
lated between the two devices [Figure 2]. The bias and lim-
its of agreement for the percentage changes in the cardiac
outputs between the two measurements were as follows:
at one hour -3.5 ± 20%, at two hours 5.6 ± 24%, at four
hours -0.4 ± 25% and at eight hours 1.4 ± 43% [Figure 2].
The separate plots of PulseCo and LiDCO against time for
each patient [Figure 4] show how the two techniques track
cardiac output. The graphs show that for the majority of
patients the magnitude and direction of change in cardiac
output is similar indicating that the two devices track car-
diac output appropriately. In a few patients, this relation-
ship is not so good, and this partly explains the percentage
Table 1: Patient Characteristics at Baseline. HAP is hospital acquired pneumonia, CAP is community acquired pneumonia.
Patient Age Sex Height (cm) Weight (kg) Diagnosis
1 53 Male 190 80 Acute pancreatitis
2 32 Female 159 150 Acute heart failure post pregnancy
3 68 Female 166 45 Septic shock secondary to CAP
4 65 Female 160 110 Septic shock secondary to abdominal sepsis
5 28 Female 160 53 Acute heart failure post pregnancy
6 33 Male 184 106 Septic shock secondary to abdominal sepsis
7 89 Female 160 50 Haemorrhagic shock
8 62 Male 165 57 Septic shock secondary to CAP
9 84 Female 174 60 Acute heart failure following haemorrhagic shock
10 72 Male 178 189 Septic shock secondary to HAP
11 83 Male 170 60 Septic shock secondary to HAP
12 71 Female 148 70 Septic shock secondary to HAP
13 76 Male 169 90 Septic shock
14 73 Female 152 65 Cardiogenic shockBMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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error for the limits of agreement that are detailed above.
Although the accuracy of cardiac output measured by the
PulseCO system remained adequate for the first four
hours of the study it is important to recognize that in indi-
vidual patients the accuracy over time varied considerably
[Figure 3] with a tendency for the percentage errors to
increase [Figure 3]. The six patients with the highest
changes in cardiac output, however, did not have the larg-
est percentage errors in the readings of cardiac output
between LiDCO and PulseCO, with the average error in
this group being 17%.
Discussion
This study assesses how well the PulseCO algorithm
maintains its accuracy in a mixed group of critically ill
patients. We deliberately chose to study critically ill
patients whose cardiac output was being monitored for
clinical reasons, as these are often the groups of patients
that these devices are used in, but are rarely the groups of
patients that they are validated for. Despite these challeng-
ing conditions we were able to demonstrate that the Pul-
seCO algorithm is an acceptable method to measure
cardiac output for up to four hours without re-calibration.
Continuous measurement of cardiac output is becoming
increasingly popular. The two most popular devices that
provide continuous CO from the analysis of arterial pres-
sure waveform are the PiCCOplus (Pulsion medical sys-
tem, Munich, Germany) [1,4,5]and Lidco™plus (LidCO,
Cambridge, UK) [3,7-10]. PiCCOplus has been commer-
cially available for longer and both its calibration system
and continuous cardiac output system have been vali-
dated in different clinical scenes. The algorithm has been
validated against both pulmonary and transpulmonary
thermodilution. It has been demonstrated to be accurate
so long as re-calibration is performed in case of major
haemodynamic change[1,2,5]. Most of the validation
studies of continuous cardiac output monitoring from the
Table 2: Patient haemodynamics at baseline and after eight hours of study or at study completion. 
Baseline Measurements Measurements at completion of study
HR MAP CO NorEpi HR MAP CO NorEpi
1 103 96 8.03 0 93 95 6.04 0
2 85 119 9.01 0 97 130 9.06 0
3 101 69 4.05 0.02 106 77 6.02 0.02
4* 116 82 10.03 0.06 103 80 10.03 0.06
5 129 118 8.02 0 128 113 7.07 0
6* 121 80 14.08 0.01 118 85 15.01 0.01
7 68 85 2.08 0 90 78 4.01 0
8 118 79 8.08 0.02 71 99 5.06 0.02
9 82 100 3.07 0 110 100 3.06 0
10 117 66 18.03 0.02 109 70 14.05 0.02
11 115 80 4.09 0 134 71 5.03 0
12 99 66 6.02 0 108 76 5.00 0
13 105 64 5.06 0.03 110 72 4.07 0.03
14 89 83 6.08 0.01 83 84 5.02 0.01
HR is heart rate (/minute), MAP is mean arterial pressure (mmHg), CO is cardiac output (L/min) and NorEpi is dose of norepinephrine in mcg/kg/
min. * describes the patients where the second set of measurements was taken at four hours rather than eight due to being removed from the 
study.
Table 3: Table demonstrating haemodynamic measurements from the LiDCO and PulseCO monitors for up to eight hours. HR, MAP, 
CVP, LiDCO and PulseCO (median and IQR), bias and percentage error at measurements intervals.
Baseline +1 hour + 2 hours +4 hours +8 hours
HR/min 104 (92–117) 110 (96–123) 111 (95–117) 107 (94–117) 107 (92–110)
MAP mmHg 81 (72–93) 84 (77–93) 86 (75–98) 81 (75–88) 81 (75–99)
CVP mmHg 16 (12–19) 16 (10–20) 13 (11–18) 16 (11–21) 15 (11–16)
LiDCO L/min 7.5 (5.1–9.0) 7.0 (5.0–10.6) 6.8 (5.6–10.1) 6.4 (5.3–9.8) 5.5 (4.9–6.7)
PulseCO L/min # 7.5 (4.4–9.8) 8.6 (5.5–9.9) 7.2 (4.8–9.2) 6.1 (5.2–7.7)
Bias ± 2SD L/min # -0.3 ± 2.3 0.1 ± 1.9 -0.1 ± 2.2 0.2 ± 2.3
Percentage error # 29% 22% 28% 36%BMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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PiCCO system have been performed in patients undergo-
ing either cardiac surgery or post operative patients on the
Intensive Care Unit. Less is known about the accuracy of
these continuous CO monitors in the critically ill popula-
tion of patients.
LiDCO™plus, a more recently available system. has been
validated against the pulmonary artery catheter and trans-
pulmonary thermodilution in animals[3,6,11] and in dif-
ferent clinical scenarios in humans [7] including cardiac
surgery and in post surgical patients [8-10]. There are no
data comparing subsequent readings from the PulseCO
(after initial calibration) in a mixed adult intensive care
population. Pitmann et al, compared PulseCO and
LiDCO in post surgical patients[8]. Their data showed a
good bias and limits of agreement at four and eight hours
with an overall error of 27%. A previous study by Hamil-
ton et al had also shown good agreement between Pul-
seCO and LiDCO in patients following cardiac surgery
[9]. In this study a similar protocol to ours was used, cali-
brating PulseCO at the beginning and then measuring
PulseCO, LiDCO and intermittent thermodilution CO
from the pulmonary artery catheter at baseline, 2, 4, 6 and
8 hours. Good agreements were found between the three
methods. The authors concluded that following cardiac
surgery PulseCO can be used without recalibration for at
least eight hours.
This study has assessed the ability of the pulse power algo-
rithm to maintain its accuracy when compared to the
LiDCO against time. It has not compared the accuracy of
the combination of LIDCO and PulseCO to give the abso-
lute cardiac output. This would need a further independ-
ent measurement technique of cardiac output as a
Linear regression and Bland Altman plots for PulseCO versus LiDCO at 1 (a), 2 (b), 4 (c) and 8 (d) hours following calibration Figure 1
Linear regression and Bland Altman plots for PulseCO versus LiDCO at 1 (a), 2 (b), 4 (c) and 8 (d) hours following calibration. 
The solid lines in the Bland Altman plot represent the bias and the dotted lines represent the limits of agreement (2 × standard 
deviation of the bias).BMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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Linear regression and Bland Altman plots for percentage changes in PulseCO versus changes in LiDCO at 1 (a), 2 (b), 4 (c) and  8 (d) hours following calibration Figure 2
Linear regression and Bland Altman plots for percentage changes in PulseCO versus changes in LiDCO at 1 (a), 2 (b), 4 (c) and 
8 (d) hours following calibration. The solid line in the regression plots represents the regression line, the dotted lines repre-
sent the 95% confidence intervals around this line. The solid lines in the Bland Altman plot represent the bias and the dotted 
lines represent the limits of agreement (2 × standard deviation of the bias).BMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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reference. In our population we found an acceptable
agreement between PulseCO and LiDCO for the first four
hours following calibration of the device and a reasonable
ability of the algorithm to track changes in this variable
within this time window. This agreement may in part
relate to the wide range of cardiac outputs that our
patients presented with in comparison to the relatively
small changes in the variable seen over the first few hours.
This raises the possibility that the relationship may in fact
be a spurious artefact of the analysis rather than a real phe-
nomenon. Four hours following calibration, however, the
percentage error increased to levels that we had pre-
defined as not being adequate. We calculated the percent-
age error of the limits of agreement as described by Critch-
ley and Critchley[13]. This technique involves calculating
the percentage error for agreement between two tech-
niques. This is normally quoted as needing to be less than
30%. This does not mean that the error for the tested tech-
nique is 30%, as this is the value of the combination of
both standard deviations. In deed if the reference tech-
nique has a precision of 10%, a value of 30% would
roughly equate to a precision for the mew methodology of
10% also. At one, two and four hours the limits of agree-
ment were 29%, 22% and 28% respectively. At eight
hours the percentage error reached 36%. It must be
stressed that the pulse pressure algorithm is essentially a
software based computer equation, and therefore cannot
cause increased errors over time. The increased errors can
only be due to one of three causes- one degraded informa-
tion from the arterial system, for instance from damping
of the arterial signal, secondly due to a change in the indi-
vidual patients haemodynamic profile, specifically
changes in arterial compliance, resistance or impedance
and lastly due to an error in the reference technique. We
are confident in our patients that the arterial signal was of
an optimal characteristic, as tested by the square wave test.
The errors must therefore be due to either changing
haemodynamic characteristics or a higher than expected
variability in the lithium dilution cardiac output method-
ology.
Limitations of our study include the fact that we used a
small number of patients in a single centre. Our popula-
tion had a high level of heterogeneity therefore our results
need to be confirmed by bigger studies with more homo-
geneous groups of patients. This may make our results less
generalizable to other populations and settings. We chose
to follow the manufacturer's recommendations for the
measurement of cardiac output from the lithium dilution
technique. This approach utilized only one lithium dilu-
tion curve. To our knowledge there is little data describing
the inter and intra observer characteristics of performing
this technique. To overcome this we ensured that only two
researchers who were both extensively trained in the tech-
nique performed the measurements. It is of note, that Pitt-
man in his study performed two calibration curves at each
time point and in any case of more than 10% variability
used an average of three measurements. We did not use
this approach, and this may explain some of the variabil-
ity. It is worth noting, however, that the technique we
Percentage errors between PulseCO and LiDCO for Individual patients over an eight hour period Figure 3
Percentage errors between PulseCO and LiDCO for Individual patients over an eight hour period.BMC Anesthesiology 2008, 8:3 http://www.biomedcentral.com/1471-2253/8/3
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Graphs representing values of cardiac output for each individual patient as measured by both LiDCO and PulseCO Figure 4
Graphs representing values of cardiac output for each individual patient as measured by both LiDCO and PulseCO.Publish with BioMed Central    and   every 
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used is the method recommended by the manufacturers
and is how this monitor is used in Intensive Care Units
around the world regularly.
Conclusion
In conclusion we have found that in a mixed group of crit-
ically ill patients, the pulse power algorithm remained
acceptable for the first four hours following calibration.
This finding is valid for the whole group but may mask
important changes on individual patients. We thus rec-
ommend in the critically ill patient group that the device
should be re-calibrated at least every four hours. Until fur-
ther data becomes available we would suggest re-calibra-
tion is performed utilizing at least two lithium dilution
curves in order to reduce variability in the technique and
improve accuracy. We would also suggest that for any
patient where there is a significant change in the haemo-
dynamic status it would be prudent to perform a re-cali-
bration prior to initiating any major therapeutic change
even if it is within this four hour window. Further studies
should be performed to better understand exactly when
re-calibrations should be performed for individual
patients, as in some it may be significantly less than the
fours hours suggested by this data.
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